What does Farmakin do?

Farmakin is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 12 July 2022, 1 establishment.

What is the address of Farmakin?

The registered office of Farmakin is located at Clarissenstraat 30, 9000 Gent.

Is Farmakin still active?

Yes. According to the CBE (2 November 2026) Farmakin is active, legal situation “Normale toestand”, started on 12 July 2022.

Is Farmakin registered on Peppol?

Yes, Farmakin is registered on the Peppol network with ID 0208:0788503201.

What is the enterprise number of Farmakin?

The enterprise number of Farmakin is BE0788503201.

When was Farmakin founded?

Farmakin was founded on 12 July 2022.

Who are the directors of Farmakin?

According to the 2025 annual accounts, the directors of Farmakin are: Hanna Kint.

Is Farmakin a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 July 2022; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Farmakin make in 2025?

Farmakin recorded a loss after taxes of € 3,596 in financial year 2025.

What is the revenue of Farmakin?

As a small company, Farmakin is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -429.

Farmakin (Private Limited) - Gent - BE0788503201

Dossier Farmakin, printed on 3 November 2026 from databakkes.be/en/0788503201/farmakin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Farmakin from Gent, company number BE0788503201, closed financial year 2025 with a result of € -3,596 after tax. For that financial year Farmakin recorded a gross margin of € -429 and equity of € 5,423. Compared with financial year 2024, the result moved from € 10,867 to € -3,596. The company made a loss. The buffer shrank hard: equity is 84 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 29, 2026.

What it is worth Shrank hard

€ 5,423

▼ 84% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -3,596

▼ still € 10,867 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,949

▼ 90% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 5,303.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,867

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 986

▲ 72% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,999

▼ 34% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 32,559 Gross margin 2023: € 32,559 First fiscal year in the series	€ 16,345 Gross margin 2024: € 16,345 ▼ 50% vs 2023 (€ 32,559) Unfavourable step	€ -429 Gross margin 2025: € -429 ▼ € 16,774 vs 2024 (€ 16,345) Unfavourable step	▼ € 16,774
Profit after taxes	€ 23,033 Profit after taxes 2023: € 23,033 First fiscal year in the series	€ 10,867 Profit after taxes 2024: € 10,867 ▼ 53% vs 2023 (€ 23,033) Unfavourable step	€ -3,596 Profit after taxes 2025: € -3,596 ▼ € 14,463 vs 2024 (€ 10,867) Unfavourable step	▼ € 14,463
Equity	€ 23,153 Equity 2023: € 23,153 First fiscal year in the series	€ 34,019 Equity 2024: € 34,019 ▲ 47% vs 2023 (€ 23,153) Favourable step	€ 5,423 Equity 2025: € 5,423 ▼ 84% vs 2024 (€ 34,019) Unfavourable step	▼ 84%
Total debts	€ 13,915 Total debts 2023: € 13,915 First fiscal year in the series	€ 9,771 Total debts 2024: € 9,771 ▼ 30% vs 2023 (€ 13,915) Favourable step	€ 8,532 Total debts 2025: € 8,532 ▼ 13% vs 2024 (€ 9,771) Favourable step	▼ 13%
Cash	€ 30,624 Cash 2023: € 30,624 First fiscal year in the series	€ 18,809 Cash 2024: € 18,809 ▼ 39% vs 2023 (€ 30,624) Unfavourable step	€ 1,949 Cash 2025: € 1,949 ▼ 90% vs 2024 (€ 18,809) Unfavourable step	▼ 90%
Retained profit	€ 23,033 Retained profit 2023: € 23,033 First fiscal year in the series	€ 33,899 Retained profit 2024: € 33,899 ▲ 47% vs 2023 (€ 23,033) Favourable step	€ 5,303 Retained profit 2025: € 5,303 ▼ 84% vs 2024 (€ 33,899) Unfavourable step	▼ 84%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 25,000 Dividend 2025: € 25,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 37,067 Balance sheet total 2023: € 37,067 First fiscal year in the series	€ 43,790 Balance sheet total 2024: € 43,790 ▲ 18% vs 2023 (€ 37,067) Unchanged	€ 13,955 Balance sheet total 2025: € 13,955 ▼ 68% vs 2024 (€ 43,790) Unchanged	▼ 68%

Key figures of Farmakin, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Farmakin?

What happened at Farmakin in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 29, 2026 New annual accounts for financial year 2025: loss of € 3,596 (▼ € 14,463 vs 2024). Source: NBB ↗
Jul 14, 2022 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jul 12, 2022 New establishment in Gent. KBO

In short

From € 23,033 profit in 2023 to € 3,596 loss in 2025.

Paid € 9,481 in corporate taxes since 2023.

Best year ever: 2023, with € 23,033 profit.

Paid out € 25,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Hanna Kint

Farmakin

Behind Farmakin is Hanna Kint.

Directors

According to the 2025 annual accounts

Hanna Kint

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Clarissenstraat 30

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

14 July 2022 Source: Deed ↗

Kint, Hanna Marie-Louise Louis(oprichter/vennoot) 100%

Details

Company number: 0788.503.201
VAT number: BE 0788.503.201
Registered office: Clarissenstraat 30, 9000 Gent
Names & denominations: Farmakin
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 July 2022
Peppol: Active · Active since 19 Nov 2025
Activities · NACE: Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗